Is heart failure guideline adherence being underestimated? the impact of therapeutic contraindications

American Heart Journal

Volumn 164, Issue 5, 2012, Pages

  Atwater, Brett D ^a,b   Dai, David ^c   Allen Lapointe, Nancy M ^a,c   Al Khatib, Sana M ^a,c   Zimmer, Louise O ^c   Sanders, Gillian D ^c   Peterson, Eric D ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 84868608362     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.08.002     Document Type: Article

References (23)

1. J.M. Aranda Jr., J.B. Conti, and J.W. Johnson Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Clin Cardiol 27 2004 678 682
2. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 480 486
3. L.J. Kozak, K.A. Lees, and C.J. DeFrances National Hospital Discharge Survey: 2003 annual summary with detailed diagnosis and procedure data Vital Health Stat 13 2006 1 206
4. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
5. M.A. Pfeffer, E. Braunwald, and L.A. Moyé Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 327 1992 669 677
6. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
7. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
8. M. Packer, A.J. Coats, and M.B. Fowler Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
9. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
10. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
11. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
12. J.G.F. Cleland, J.-C. Daubert, and E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
13. S.A. Hunt, and W.T. Abraham 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults Circulation 119 2009 e391 e479
14. G.C. Fonarow, W.G. Stough, and W.T. Abraham Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
15. G.C. Fonarow, N.M. Albert, and A.B. Curtis Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596
16. N.M. Albert, C.W. Yancy, and L. Liang Use of aldosterone antagonists in heart failure JAMA 302 2009 1658 1665
17. C. Zugck, A. Haunstetter, and C. Kruger Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure J Am Coll Cardiol 39 2002 1615 1622
18. J. Lindenfeld, N.M. Albert, and J.P. Boehmer HFSA 2010 Comprehensive Heart Failure Practice Guideline J Card Fail 16 2010 e1 e194
19. J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
20. M. Steinman, J. Harlow, and B. Massie Age and receipt of guideline-recommended medications for heart failure: a nationwide study of veterans J Gen Intern Med 26 2011 1152 1159
21. E.P. Havranek, P. Wolfe, and F.A. Masoudi Provider and hospital characteristics associated with geographic variation in the evaluation and management of elderly patients with heart failure Arch Intern Med 164 2004 1186 1191
22. A.J. Kirtane, A.M. Rahman, and P. Martinezclark Adherence to American College of Cardiology/American Heart Association Guidelines for the Management of Anticoagulation in Patients With Mechanical Valves Undergoing Elective Outpatient Procedures Am J Cardiol 97 2006 891 893
23. N.M. LaPointe, S.M. Al-Khatib, and J.P. Piccini Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction Circ Cardiovasc Qual Outcomes 4 2011 146 151